| Application no. and date | 20151107.8 (espacenet) (Federated) (European Patent Register), 20160413 | | Patent/reg. no. and date | DK/EP 3666768, 20220615 | | Publication date | 20200617 | | Priority no. and date | US 201562152108 P, 20150424 | | EP pub. no. and date |
EP 3666768 20200617 | | Effective date | | | Applicant/owner | Pfizer Inc., 66 Hudson Boulevard East
New York, NY 10001-2192, US | | Applicant ref. no. | V444127DK00 | | Inventor | HANSEN, Eric Christian, 44 Renee Drive
Pawcatuck, CT 06379, US,
SEADEEK, Christopher Scott, 3350 Whirlaway Court
West Lafayette, IN 47906, US,
RANE, Anil Mahadeo, c/o Pfizer Inc.
445 Eastern Point Road
Building 98
Groton, Connecticut 06340, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61P 35/00 (2006.01) , A61P 43/00 (2006.01) , C07D 401/04 (2006.01) | | Title | Fremgangsmåde til fremstilling af en krystallinsk form af 1-((2R,4R)-2-(1H-benzo[D]imidazol-2-yl)-1-methylpiperidin-4-yl)-3-(4-cyanophenyl)ureamaleat; krystallinsk form af 1-((2R,4R)-2-(1H-benzo[D]imidazol-2-YL)-1-methylpiperidin-4-YL)-3-(4- | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
